The genomic diagnostics company saw revenue rise to $30.14 million from $22.8 million in the comparable quarter a year ago. The result also topped analysts' average estimate of $29.16 million.
Moving forward, Veracyte said it is raising its 2019 annual revenue guidance to a range of $119 million to $122 million from its previous forecast of $117 million to $121 million. Forecasts are for sales of $120.54 million.
Price: 29.61, Change: +0.43, Percent Change: +1.47
|Insider Trends: 90-Day Insider Buying Trend at Guide...|
|Insider Trends: 90-Day Insider Buying Trend Reduced ...|
|Insider Trends: 90-Days of Insider Buying at Guidewi...|
|Insider Trends: Guidewire Software Sees 90 Days of I...|
|Insider Trends: Insider Adds to Selling Trend at Eag...|